Ultragenyx Pharmaceutical Inc.

Insider Reports History

Entity
Company
Location
60 Leveroni Court, Novato, CA
Signature
/s/ Mardi C. Dier, EVP and Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ultragenyx Pharmaceutical Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcturus Therapeutics Holdings Inc. Director Common Stock 1.4M $26.2M $18.72 Aug 11, 2021 Direct

Insider Reports Filed by Ultragenyx Pharmaceutical Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARCT Arcturus Therapeutics Holdings Inc. Aug 10, 2021 2 -$43.6M 4 Aug 12, 2021 Director